Cogent Biosciences Q4 EPS $(0.61) Misses $(0.53) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.53) by 15.97 percent. This is a 577.78 percent decrease over losses of $(0.09) per share
Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.53) by 15.97 percent. This is a 577.78 percent decrease over losses of $(0.09) per share from the same period last year.